Colgate-Palmolive stock got a rating downgrade from analysts at Bank of America Securities.
BofA Securities cut their rating on the shares of the consumer products’ maker to neutral from buy.
BofA analyst Olivia Tong lowered her price target on the shares to $74 a share from $77 (as reported in Bloomberg ). According to the analyst, the company struggles with declining shares in toothpaste despite aggressive stance in driving growth. Tong also indicated that Colgate-Palmolive might face even more challenging conditions next year, and that the situation could necessitate another year of outsized investment.
The Aroon Indicator for CL entered a downward trend on February 04, 2025. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 205 similar instances where the Aroon Indicator formed such a pattern. In of the 205 cases the stock moved lower. This puts the odds of a downward move at .
The Momentum Indicator moved below the 0 level on January 31, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CL as a result. In of 77 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
CL broke above its upper Bollinger Band on January 27, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CL's RSI Oscillator exited the oversold zone, of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The Moving Average Convergence Divergence (MACD) for CL just turned positive on January 17, 2025. Looking at past instances where CL's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CL's P/B Ratio (120.482) is slightly higher than the industry average of (17.160). P/E Ratio (32.152) is within average values for comparable stocks, (204.360). Projected Growth (PEG Ratio) (2.232) is also within normal values, averaging (3.832). Dividend Yield (0.022) settles around the average of (0.107) among similar stocks. P/S Ratio (3.795) is also within normal values, averaging (115.095).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a maker of oral, personal, and household products
Industry HouseholdPersonalCare